FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonia Busse

Research Profile

Chemicals & Drugs

Procedures

Disorders

Genes & Molecular Sequences

Wilms' Tumor Genes

Anatomy

Concepts & Ideas

Kaplan-Meier Estimate

Co-author Network

Publications

TOP 3
Martin Schmidt-Hieber; Eckhard Thiel; Carola Tietze-Buerger; Babette Aicher; Antonia Busse; Robert Dabrowski; Philipp Lohneis; Birgit Reufi; Igor Wolfgang Blau
In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.
Martin Schmidt-Hieber; Eckhard Thiel; Andreas Weimann; Babette Aicher; Antonia Busse; Robert Dabrowski; Philipp Lohneis; Igor Wolfgang Blau
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.
Sebastian Ochsenreither; David Stather; Andrea Stroux; Anne Letsch; Antonia Busse; Alberto Fusi; Anne Geikowski; Ulrich Keilholz
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonia Busse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Martin Schmidt-Hieber; Eckhard Thiel; Carola Tietze-Buerger; Babette Aicher; Antonia Busse; Robert Dabrowski; Philipp Lohneis; Birgit Reufi; Igor Wolfgang Blau
In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.
Investigational new drugs 2012;30(4):1396-403.
2012: Martin Schmidt-Hieber; Eckhard Thiel; Andreas Weimann; Babette Aicher; Antonia Busse; Robert Dabrowski; Philipp Lohneis; Igor Wolfgang Blau
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.
Investigational new drugs 2012;30(2):480-9.
2012: Sebastian Ochsenreither; David Stather; Andrea Stroux; Anne Letsch; Antonia Busse; Alberto Fusi; Anne Geikowski; Ulrich Keilholz
Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.
Cancer immunology, immunotherapy : CII 2012;61(3):313-22.
2011: Antonia Busse; Anne Marie Asemissen; Anika Nonnenmacher; Floriane Braun; Sebastian Ochsenreither; David Stather; Alberto Fusi; Alexander Schmittel; Kurt Miller; Eckhard Thiel; Ulrich Keilholz
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2011;47(5):690-6.
2011: Alberto Fusi; Uta Reichelt; Antonia Busse; Sebastian Ochsenreither; Anika Rietz; Markus Maisel; Ulrich Keilholz
Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
The Journal of investigative dermatology 2011;131(2):487-94.
2011: Ronny Schuster; Andrea Stroux; Eckhard Thiel; Alexander Schmittel; Nikolaos E Bechrakis; Antonia Busse; Michael H Foerster; Ulrich Keilholz
Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
Oncology 2011;80(1-2):57-62.
2010: A Fusi; S Ochsenreither; Antonia Busse; A Rietz; Ulrich Keilholz
Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.
The British journal of dermatology 2010;163(1):107-14.
2010: Sandra Heesch; Nicola Goekbuget; Andrea Stroux; Jutta Ortiz Tanchez; Cornelia Schlee; Thomas Burmeister; Stefan Schwartz; Olga Blau; Ulrich Keilholz; Antonia Busse; Dieter Hoelzer; Eckhard Thiel; Wolf-Karsten Hofmann; Claudia D Baldus
Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
Haematologica 2010;95(6):942-9.
2010: Sebastian Ochsenreither; Alberto Fusi; Antonia Busse; Anne Letsch; Doreen Haase; Eckhard Thiel; Carmen Scheibenbogen; Ulrich Keilholz
Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma.
International journal of cancer. Journal international du cancer 2010;126(10):2497-502.
2010: Sebastian Ochsenreither; Alberto Fusi; Susanne Wojtke; Antonia Busse; Natascha C Nüssler; Eckhard Thiel; Ulrich Keilholz; Dirk Nagorsen
Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.
Journal of translational medicine 2010;8():35.
2010: Antonia Busse; Anne Letsch; Carmen Scheibenbogen; Anika Nonnenmacher; Sebastian Ochsenreither; Eckhard Thiel; Ulrich Keilholz
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination.
Journal of translational medicine 2010;8():5.
2009: Antonia Busse; Nicola Gökbuget; Jan M Siehl; Dieter Hoelzer; Stefan Schwartz; Anika Rietz; Eckhard Thiel; Ulrich Keilholz
Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Annals of hematology 2009;88(12):1199-205.
2009: Ulrich Keilholz; Anne Letsch; Antonia Busse; Anne Marie Asemissen; Sandra Bauer; Igor Wolfgang Blau; Wolf-Karsten Hofmann; Lutz Uharek; Eckhard Thiel; Carmen Scheibenbogen
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.
Blood 2009;113(26):6541-8.
2009: Anne Marie Asemissen; Doreen Haase; Stefan Stevanovic; Sandra Bauer; Antonia Busse; Eckhard Thiel; Hans-Georg Rammensee; Ulrich Keilholz; Carmen Scheibenbogen
Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):370-5.
2009: Antonia Busse; Anika Rietz; Stefan Schwartz; Eckhard Thiel; Ulrich Keilholz
An intron 9 containing splice variant of PAX2.
Journal of translational medicine 2009;7():36.
2008: Il-Kang Na; Antonia Busse; Carmen Scheibenbogen; Pirus Ghadjar; Sarah Ellen Coupland; Anne Letsch; Christoph Loddenkemper; Andrea Stroux; Sandra Bauer; Eckhard Thiel; Ulrich Keilholz
Identification of truncated chemokine receptor 7 in human colorectal cancer unable to localize to the cell surface and unreactive to external ligands.
International journal of cancer. Journal international du cancer 2008;123(7):1565-72.
2008: Antonia Busse; Marianne Kraus; Il-Kang Na; Anika Rietz; Carmen Scheibenbogen; Christoph Driessen; Igor Wolfgang Blau; Eckhard Thiel; Ulrich Keilholz
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
Cancer 2008;112(3):659-70.
2008: Sebastian Ochsenreither; Alberto Fusi; Antonia Busse; Dirk Nagorsen; David Schrama; Jürgen Becker; Eckhard Thiel; Ulrich Keilholz
Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations.
Journal of translational medicine 2008;6():34.
2007: Antonia Busse; Gero Hütter; Jan M Siehl; Alexander Schmittel; Eckhard Thiel; Ulrich Keilholz
A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.
Leukemia & lymphoma 2007;48(9):1755-63.
2007: Ronny Schuster; Nikolaos E Bechrakis; Andrea Stroux; Antonia Busse; Alexander Schmittel; Carmen Scheibenbogen; Eckhard Thiel; Michael H Foerster; Ulrich Keilholz
Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1171-8.
2006: Robert Godal; Ulrich Keilholz; Lutz Uharek; Anne Letsch; Anne Marie Asemissen; Antonia Busse; Il-Kang Na; Eckhard Thiel; Carmen Scheibenbogen
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
Blood 2006;107(8):3205-11.